According to a research letter published in JAMA Internal Medicine, prostate cancer screening frequently results in biopsies that find clinically insignificant cancer or no cancer at all.
A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, according to a study by researchers at Penn State, Stanford University and an international ...
Aug 22, 2024
0
32
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published in JAMA ...
Jul 16, 2024
0
19
A research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty ...
Jul 10, 2024
0
36
People may be at increased risk from cancer, diabetes, cardiovascular disease, and chronic lung disease—as rising global levels of micro- and nanoplastics (MnPs) are absorbed into the human body, a new study reveals.
Jun 21, 2024
0
37
To prevent an emerging genomic technology from contributing to health disparities, a scientific team has devised new ways to improve a genetic testing method called a polygenic risk score. Since polygenic risk scores have ...
Feb 19, 2024
0
2
A protein that has been widely studied owing to its association with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) is also linked to medulloblastoma, a type of central nervous system cancer. Medulloblastoma ...
Feb 7, 2024
0
38
Physician-investigators at Beth Israel Deaconess Medical Center (BIDMC) compared a chatbot's probabilistic reasoning to that of human clinicians. The findings, published in JAMA Network Open, suggest that artificial intelligence ...
Dec 11, 2023
0
15
Polygenic risk scores, which estimate a person's disease risk based on thousands or millions of common genetic variants, perform poorly in screening and prediction of common diseases such as heart disease, according to a ...
Oct 17, 2023
0
60
A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published ...
Sep 27, 2023
0
34
